Safety of an extended-release injectable moxidectin suspension formulation (ProHeart® 12) in dogs
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-3305
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Safety of an extended-release injectable moxidectin suspension formulation (ProHeart® 12) in dogs ; volume:12 ; number:1 ; day:6 ; month:9 ; year:2019 ; pages:1-13 ; date:12.2019
Parasites & vectors ; 12, Heft 1 (6.9.2019), 1-13, 12.2019
- Creator
-
Krautmann, Matthew J.
Mahabir, Sean
Fielder, Ann
Collard, Wendy
Wolthuis, Tracie L.
Esch, Kevin
Morton, Tracy
Alleman, Kent
Luo, Laibin
McCandless, Erin
Nederveld, Steven
Kryda, Kristina
Carroll, Ryan
Boucher, Joseph F.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13071-019-3690-6
- URN
-
urn:nbn:de:101:1-2020012319133797319004
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Krautmann, Matthew J.
- Mahabir, Sean
- Fielder, Ann
- Collard, Wendy
- Wolthuis, Tracie L.
- Esch, Kevin
- Morton, Tracy
- Alleman, Kent
- Luo, Laibin
- McCandless, Erin
- Nederveld, Steven
- Kryda, Kristina
- Carroll, Ryan
- Boucher, Joseph F.
- SpringerLink (Online service)
Other Objects (12)
Efficacy of semi-annual therapy of an extended-release injectable moxidectin suspension and oral doxycycline in Dirofilaria immitis naturally infected dogs
ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Efficacy of oral, topical and extended-release injectable formulations of moxidectin combined with doxycycline in Dirofilaria immitis naturally infected dogs
Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa–Levodopa
A single treatment with a fluralaner injectable suspension (Bravecto® injectable) provides 1-year efficacy against Rhipicephalus sanguineus sensu lato and Ctenocephalides felis in dogs
Sodium oxybate extended-release suspension (LUMRYZ™) in narcolepsy: a profile of its use
Correction: Sodium oxybate extended-release suspension (LUMRYZ™) in narcolepsy: a profile of its use
Year-round efficacy of a single treatment of fluralaner injectable suspension (Bravecto QuantumTM) against repeated infestations with Ixodes holocyclus in dogs
Population Pharmacokinetics of an Extended-Release Formulation of Exenatide Following Single- and Multiple-Dose Administration
Formulation development of a highly concentrated suspension of Cilengitide
Changes in Pramipexole Utilization after Introduction of the Extended-Release Formulation: A Nationwide Study in Taiwan
Efficacy of semi-annual therapy of an extended-release injectable moxidectin suspension and oral doxycycline in Dirofilaria immitis naturally infected dogs
ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Efficacy of oral, topical and extended-release injectable formulations of moxidectin combined with doxycycline in Dirofilaria immitis naturally infected dogs
Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa–Levodopa
A single treatment with a fluralaner injectable suspension (Bravecto® injectable) provides 1-year efficacy against Rhipicephalus sanguineus sensu lato and Ctenocephalides felis in dogs
Sodium oxybate extended-release suspension (LUMRYZ™) in narcolepsy: a profile of its use
Correction: Sodium oxybate extended-release suspension (LUMRYZ™) in narcolepsy: a profile of its use
Year-round efficacy of a single treatment of fluralaner injectable suspension (Bravecto QuantumTM) against repeated infestations with Ixodes holocyclus in dogs
Population Pharmacokinetics of an Extended-Release Formulation of Exenatide Following Single- and Multiple-Dose Administration
Formulation development of a highly concentrated suspension of Cilengitide
Changes in Pramipexole Utilization after Introduction of the Extended-Release Formulation: A Nationwide Study in Taiwan
Efficacy of semi-annual therapy of an extended-release injectable moxidectin suspension and oral doxycycline in Dirofilaria immitis naturally infected dogs
ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Efficacy of oral, topical and extended-release injectable formulations of moxidectin combined with doxycycline in Dirofilaria immitis naturally infected dogs
Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa–Levodopa
A single treatment with a fluralaner injectable suspension (Bravecto® injectable) provides 1-year efficacy against Rhipicephalus sanguineus sensu lato and Ctenocephalides felis in dogs
Sodium oxybate extended-release suspension (LUMRYZ™) in narcolepsy: a profile of its use
Correction: Sodium oxybate extended-release suspension (LUMRYZ™) in narcolepsy: a profile of its use
Year-round efficacy of a single treatment of fluralaner injectable suspension (Bravecto QuantumTM) against repeated infestations with Ixodes holocyclus in dogs
Population Pharmacokinetics of an Extended-Release Formulation of Exenatide Following Single- and Multiple-Dose Administration
Formulation development of a highly concentrated suspension of Cilengitide